1h Free Analyst Time
The global doxorubicin market is forecasted to grow by USD 625.8 million during 2025-2030, accelerating at a CAGR of 6.8% during the forecast period. The report on the global doxorubicin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, increasing product launches of doxorubicin, advancements in diagnostic methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global doxorubicin market is segmented as below:
By Formulation
- Lyophilized powder
- Doxorubicin injection
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
- Others
By Application
- Breast cancer
- Leukemia
- Lymphoma
- Bladder cancer
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
The report on the global doxorubicin market covers the following areas:
- Global doxorubicin market sizing
- Global doxorubicin market forecast
- Global doxorubicin market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Formulation
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Doxorubicin Market 2020 - 2024
- Historic Market Size - Data Table on Global Doxorubicin Market 2020 - 2024 ($ million)
- Historic Market Size - Formulation Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Doxorubicin Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Formulation
8.1 Market segments
- Chart on Formulation - Market share 2025-2030 (%)
- Data Table on Formulation - Market share 2025-2030 (%)
- Chart on Comparison by Formulation
- Data Table on Comparison by Formulation
- Chart on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
- Data Table on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
- Chart on Lyophilized powder - Year-over-year growth 2025-2030 (%)
- Data Table on Lyophilized powder - Year-over-year growth 2025-2030 (%)
- Chart on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
- Data Table on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
- Chart on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
- Data Table on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
- Market opportunity by Formulation ($ million)
- Data Table on Market opportunity by Formulation ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application
10.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
- Chart on Leukemia - Market size and forecast 2025-2030 ($ million)
- Data Table on Leukemia - Market size and forecast 2025-2030 ($ million)
- Chart on Leukemia - Year-over-year growth 2025-2030 (%)
- Data Table on Leukemia - Year-over-year growth 2025-2030 (%)
- Chart on Lymphoma - Market size and forecast 2025-2030 ($ million)
- Data Table on Lymphoma - Market size and forecast 2025-2030 ($ million)
- Chart on Lymphoma - Year-over-year growth 2025-2030 (%)
- Data Table on Lymphoma - Year-over-year growth 2025-2030 (%)
- Chart on Bladder cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Bladder cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Bladder cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Bladder cancer - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Growing prevalence of cancer cases
- Increasing product launches of doxorubicin
- Advancements in diagnostic methods
- Late diagnosis and poor survival of patients with cancer
- Lack of approved drugs
- Side effects of substitute medications of doxorubicin
- Impact of drivers and challenges in 2025 and 2030
- Introduction of precision cancer medicine
- Rise in research and development of innovative biologics
- Increasing inorganic growth strategies by companies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Pharmagen CZ s.r.o - Overview
- Pharmagen CZ s.r.o - Product / Service
- Pharmagen CZ s.r.o - Key offerings
- SWOT
- S. G. Biopharm Pvt. Ltd. - Overview
- S. G. Biopharm Pvt. Ltd. - Product / Service
- S. G. Biopharm Pvt. Ltd. - Key offerings
- SWOT
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- Synbias Pharma AG - Overview
- Synbias Pharma AG - Product / Service
- Synbias Pharma AG - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Doxorubicin Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Formulation Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Formulation - Market share 2025-2030 (%)
Exhibit 39: Data Table on Formulation - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Formulation
Exhibit 41: Data Table on Comparison by Formulation
Exhibit 42: Chart on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Lyophilized powder - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Lyophilized powder - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Formulation ($ million)
Exhibit 51: Data Table on Market opportunity by Formulation ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Distribution Channel ($ million)
Exhibit 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 74: Chart on Application - Market share 2025-2030 (%)
Exhibit 75: Data Table on Application - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Application
Exhibit 77: Data Table on Comparison by Application
Exhibit 78: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Leukemia - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Leukemia - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Leukemia - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Leukemia - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Lymphoma - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Lymphoma - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Lymphoma - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Lymphoma - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Bladder cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Bladder cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Bladder cancer - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Bladder cancer - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Application ($ million)
Exhibit 99: Data Table on Market opportunity by Application ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Baxter International Inc. - Overview
Exhibit 231: Baxter International Inc. - Business segments
Exhibit 232: Baxter International Inc. - Key news
Exhibit 233: Baxter International Inc. - Key offerings
Exhibit 234: Baxter International Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Cipla Inc. - Overview
Exhibit 237: Cipla Inc. - Business segments
Exhibit 238: Cipla Inc. - Key news
Exhibit 239: Cipla Inc. - Key offerings
Exhibit 240: Cipla Inc. - Segment focus
Exhibit 241: SWOT
Exhibit 242: Dr Reddys Laboratories Ltd. - Overview
Exhibit 243: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 244: Dr Reddys Laboratories Ltd. - Key news
Exhibit 245: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 246: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 247: SWOT
Exhibit 248: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 249: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 250: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 251: SWOT
Exhibit 252: Hikma Pharmaceuticals Plc - Overview
Exhibit 253: Hikma Pharmaceuticals Plc - Business segments
Exhibit 254: Hikma Pharmaceuticals Plc - Key news
Exhibit 255: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 256: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 257: SWOT
Exhibit 258: Intas Pharmaceuticals Ltd. - Overview
Exhibit 259: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 260: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Merck KGaA - Overview
Exhibit 263: Merck KGaA - Business segments
Exhibit 264: Merck KGaA - Key news
Exhibit 265: Merck KGaA - Key offerings
Exhibit 266: Merck KGaA - Segment focus
Exhibit 267: SWOT
Exhibit 268: Novartis AG - Overview
Exhibit 269: Novartis AG - Business segments
Exhibit 270: Novartis AG - Key news
Exhibit 271: Novartis AG - Key offerings
Exhibit 272: Novartis AG - Segment focus
Exhibit 273: SWOT
Exhibit 274: Pfizer Inc. - Overview
Exhibit 275: Pfizer Inc. - Product / Service
Exhibit 276: Pfizer Inc. - Key news
Exhibit 277: Pfizer Inc. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Pharmagen CZ s.r.o - Overview
Exhibit 280: Pharmagen CZ s.r.o - Product / Service
Exhibit 281: Pharmagen CZ s.r.o - Key offerings
Exhibit 282: SWOT
Exhibit 283: S. G. Biopharm Pvt. Ltd. - Overview
Exhibit 284: S. G. Biopharm Pvt. Ltd. - Product / Service
Exhibit 285: S. G. Biopharm Pvt. Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 288: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 289: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 290: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibit 291: SWOT
Exhibit 292: Synbias Pharma AG - Overview
Exhibit 293: Synbias Pharma AG - Product / Service
Exhibit 294: Synbias Pharma AG - Key offerings
Exhibit 295: SWOT
Exhibit 296: Teva Pharmaceutical Ltd. - Overview
Exhibit 297: Teva Pharmaceutical Ltd. - Business segments
Exhibit 298: Teva Pharmaceutical Ltd. - Key news
Exhibit 299: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 300: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Zydus Lifesciences Ltd. - Overview
Exhibit 303: Zydus Lifesciences Ltd. - Business segments
Exhibit 304: Zydus Lifesciences Ltd. - Key news
Exhibit 305: Zydus Lifesciences Ltd. - Key offerings
Exhibit 306: Zydus Lifesciences Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: Inclusions checklist
Exhibit 309: Exclusions checklist
Exhibit 310: Currency conversion rates for US$
Exhibit 311: Research methodology
Exhibit 312: Information sources
Exhibit 313: Data validation
Exhibit 314: Validation techniques employed for market sizing
Exhibit 315: Data synthesis
Exhibit 316: 360 degree market analysis
Exhibit 317: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Doxorubicin Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Formulation Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Formulation - Market share 2025-2030 (%)
Exhibit 39: Data Table on Formulation - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Formulation
Exhibit 41: Data Table on Comparison by Formulation
Exhibit 42: Chart on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Lyophilized powder - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Lyophilized powder - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Lyophilized powder - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Doxorubicin injection - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Doxorubicin injection - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Formulation ($ million)
Exhibit 51: Data Table on Market opportunity by Formulation ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Distribution Channel ($ million)
Exhibit 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 74: Chart on Application - Market share 2025-2030 (%)
Exhibit 75: Data Table on Application - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Application
Exhibit 77: Data Table on Comparison by Application
Exhibit 78: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Leukemia - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Leukemia - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Leukemia - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Leukemia - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Lymphoma - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Lymphoma - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Lymphoma - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Lymphoma - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Bladder cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Bladder cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Bladder cancer - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Bladder cancer - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Application ($ million)
Exhibit 99: Data Table on Market opportunity by Application ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Baxter International Inc. - Overview
Exhibit 231: Baxter International Inc. - Business segments
Exhibit 232: Baxter International Inc. - Key news
Exhibit 233: Baxter International Inc. - Key offerings
Exhibit 234: Baxter International Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Cipla Inc. - Overview
Exhibit 237: Cipla Inc. - Business segments
Exhibit 238: Cipla Inc. - Key news
Exhibit 239: Cipla Inc. - Key offerings
Exhibit 240: Cipla Inc. - Segment focus
Exhibit 241: SWOT
Exhibit 242: Dr Reddys Laboratories Ltd. - Overview
Exhibit 243: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 244: Dr Reddys Laboratories Ltd. - Key news
Exhibit 245: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 246: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 247: SWOT
Exhibit 248: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 249: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 250: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 251: SWOT
Exhibit 252: Hikma Pharmaceuticals Plc - Overview
Exhibit 253: Hikma Pharmaceuticals Plc - Business segments
Exhibit 254: Hikma Pharmaceuticals Plc - Key news
Exhibit 255: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 256: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 257: SWOT
Exhibit 258: Intas Pharmaceuticals Ltd. - Overview
Exhibit 259: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 260: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Merck KGaA - Overview
Exhibit 263: Merck KGaA - Business segments
Exhibit 264: Merck KGaA - Key news
Exhibit 265: Merck KGaA - Key offerings
Exhibit 266: Merck KGaA - Segment focus
Exhibit 267: SWOT
Exhibit 268: Novartis AG - Overview
Exhibit 269: Novartis AG - Business segments
Exhibit 270: Novartis AG - Key news
Exhibit 271: Novartis AG - Key offerings
Exhibit 272: Novartis AG - Segment focus
Exhibit 273: SWOT
Exhibit 274: Pfizer Inc. - Overview
Exhibit 275: Pfizer Inc. - Product / Service
Exhibit 276: Pfizer Inc. - Key news
Exhibit 277: Pfizer Inc. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Pharmagen CZ s.r.o - Overview
Exhibit 280: Pharmagen CZ s.r.o - Product / Service
Exhibit 281: Pharmagen CZ s.r.o - Key offerings
Exhibit 282: SWOT
Exhibit 283: S. G. Biopharm Pvt. Ltd. - Overview
Exhibit 284: S. G. Biopharm Pvt. Ltd. - Product / Service
Exhibit 285: S. G. Biopharm Pvt. Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 288: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 289: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 290: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibit 291: SWOT
Exhibit 292: Synbias Pharma AG - Overview
Exhibit 293: Synbias Pharma AG - Product / Service
Exhibit 294: Synbias Pharma AG - Key offerings
Exhibit 295: SWOT
Exhibit 296: Teva Pharmaceutical Ltd. - Overview
Exhibit 297: Teva Pharmaceutical Ltd. - Business segments
Exhibit 298: Teva Pharmaceutical Ltd. - Key news
Exhibit 299: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 300: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Zydus Lifesciences Ltd. - Overview
Exhibit 303: Zydus Lifesciences Ltd. - Business segments
Exhibit 304: Zydus Lifesciences Ltd. - Key news
Exhibit 305: Zydus Lifesciences Ltd. - Key offerings
Exhibit 306: Zydus Lifesciences Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: Inclusions checklist
Exhibit 309: Exclusions checklist
Exhibit 310: Currency conversion rates for US$
Exhibit 311: Research methodology
Exhibit 312: Information sources
Exhibit 313: Data validation
Exhibit 314: Validation techniques employed for market sizing
Exhibit 315: Data synthesis
Exhibit 316: 360 degree market analysis
Exhibit 317: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global doxorubicin market: Aurobindo Pharma Ltd., Baxter International Inc., Cipla Inc., Dr Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Pharmagen CZ s.r.o, S. G. Biopharm Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Synbias Pharma AG, Teva Pharmaceutical Ltd., TTY Biopharm Co. Ltd., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is introduction of precision cancer medicine."
According to the report, one of the major drivers for this market is the growing prevalence of cancer cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals Plc
- Intas Pharmaceuticals Ltd.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Pharmagen CZ s.r.o
- S. G. Biopharm Pvt. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Synbias Pharma AG
- Teva Pharmaceutical Ltd.
- TTY Biopharm Co. Ltd.
- Zydus Lifesciences Ltd.
